These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23437766)

  • 1. Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus.
    Wang J; Ma C; Wang J; Jo H; Canturk B; Fiorin G; Pinto LH; Lamb RA; Klein ML; DeGrado WF
    J Med Chem; 2013 Apr; 56(7):2804-12. PubMed ID: 23437766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31N Channel Blockers.
    Ma C; Zhang J; Wang J
    Mol Pharmacol; 2016 Sep; 90(3):188-98. PubMed ID: 27385729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of M2 channel blockers targeting the drug-resistant double mutants M2-S31N/L26I and M2-S31N/V27A from the influenza A viruses.
    Musharrafieh R; Ma C; Wang J
    Eur J Pharm Sci; 2020 Jan; 141():105124. PubMed ID: 31669761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.
    Li F; Ma C; Hu Y; Wang Y; Wang J
    ACS Infect Dis; 2016 Oct; 2(10):726-733. PubMed ID: 27657178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers.
    Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J
    Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flipping in the pore: discovery of dual inhibitors that bind in different orientations to the wild-type versus the amantadine-resistant S31N mutant of the influenza A virus M2 proton channel.
    Wu Y; Canturk B; Jo H; Ma C; Gianti E; Klein ML; Pinto LH; Lamb RA; Fiorin G; Wang J; DeGrado WF
    J Am Chem Soc; 2014 Dec; 136(52):17987-95. PubMed ID: 25470189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.
    Du QS; Huang RB; Wang SQ; Chou KC
    PLoS One; 2010 Feb; 5(2):e9388. PubMed ID: 20186344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Azatetracyclo[5.2.1.1(5,8).0(1,5)]undecane derivatives: from wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant.
    Rey-Carrizo M; Torres E; Ma C; Barniol-Xicota M; Wang J; Wu Y; Naesens L; DeGrado WF; Lamb RA; Pinto LH; Vázquez S
    J Med Chem; 2013 Nov; 56(22):9265-74. PubMed ID: 24237039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus.
    Wang J; Wu Y; Ma C; Fiorin G; Wang J; Pinto LH; Lamb RA; Klein ML; Degrado WF
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1315-20. PubMed ID: 23302696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoadamantanes with persistent in vitro efficacy against H1N1 (2009) influenza A.
    Kolocouris A; Tzitzoglaki C; Johnson FB; Zell R; Wright AK; Cross TA; Tietjen I; Fedida D; Busath DD
    J Med Chem; 2014 Jun; 57(11):4629-39. PubMed ID: 24793875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divalent copper complexes as influenza A M2 inhibitors.
    Gordon NA; McGuire KL; Wallentine SK; Mohl GA; Lynch JD; Harrison RG; Busath DD
    Antiviral Res; 2017 Nov; 147():100-106. PubMed ID: 29032206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design of a deuterium-containing M2-S31N channel blocker UAWJ280 with
    Cáceres CJ; Hu Y; Cárdenas-García S; Wu X; Tan H; Carnaccini S; Gay LC; Geiger G; Ma C; Zhang QY; Rajao D; Perez DR; Wang J
    Emerg Microbes Infect; 2021 Dec; 10(1):1832-1848. PubMed ID: 34427541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expeditious Lead Optimization of Isoxazole-Containing Influenza A Virus M2-S31N Inhibitors Using the Suzuki-Miyaura Cross-Coupling Reaction.
    Li F; Hu Y; Wang Y; Ma C; Wang J
    J Med Chem; 2017 Feb; 60(4):1580-1590. PubMed ID: 28182419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Highly Potent Inhibitors Targeting the Predominant Drug-Resistant S31N Mutant of the Influenza A Virus M2 Proton Channel.
    Li F; Ma C; DeGrado WF; Wang J
    J Med Chem; 2016 Feb; 59(3):1207-16. PubMed ID: 26771709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isocyanides as Influenza A Virus Subtype H5N1 Wild-Type M2 Channel Inhibitors.
    Wu S; Huang J; Gazzarrini S; He S; Chen L; Li J; Xing L; Li C; Chen L; Neochoritis CG; Liao GP; Zhou H; Dömling A; Moroni A; Wang W
    ChemMedChem; 2015 Nov; 10(11):1837-45. PubMed ID: 26506405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus.
    Duncan MC; Onguéné PA; Kihara I; Nebangwa DN; Naidu ME; Williams DE; Balgi AD; Andrae-Marobela K; Roberge M; Andersen RJ; Niikura M; Ntie-Kang F; Tietjen I
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32599753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
    Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling the in vitro drug-resistance mechanism of influenza A viruses towards the AM2-S31N proton channel blockers.
    Musharrafieh R; Ma C; Wang J
    Antiviral Res; 2018 May; 153():10-22. PubMed ID: 29518414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational studies of influenza A virus at three important targets: hemagglutinin, neuraminidase and M2 protein.
    Rungrotmongkol T; Yotmanee P; Nunthaboot N; Hannongbua S
    Curr Pharm Des; 2011; 17(17):1720-39. PubMed ID: 21619529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amantadine resistance among highly pathogenic avian influenza viruses (H5N1) isolated from India.
    Jacob A; Sood R; Chanu KhV; Bhatia S; Khandia R; Pateriya AK; Nagarajan S; Dimri U; Kulkarni DD
    Microb Pathog; 2016 Feb; 91():35-40. PubMed ID: 26639679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.